HHLR Advisors’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.7M Hold
5,980,568
0.88% 12
2025
Q4
$23.8M Hold
5,980,568
0.77% 11
2025
Q3
$22.6M Hold
5,980,568
0.55% 16
2025
Q2
$14.5M Hold
5,980,568
0.47% 17
2025
Q1
$4.93M Hold
5,980,568
0.14% 27
2024
Q4
$5.08M Sell
5,980,568
-928,652
-13% -$1.03M 0.18% 23
2024
Q3
$8.57M Hold
6,909,220
0.19% 23
2024
Q2
$11.5M Hold
6,909,220
0.28% 29
2024
Q1
$12.9M Hold
6,909,220
0.28% 27
2023
Q4
$13.1M Hold
6,909,220
0.26% 27
2023
Q3
$9.12M Hold
6,909,220
0.2% 36
2023
Q2
$20.7M Sell
6,909,220
-45,222
-0.7% -$145K 0.44% 25
2023
Q1
$24.1M Sell
6,954,442
-228,408
-3% -$1.11M 0.43% 28
2022
Q4
$30M Hold
7,182,850
0.63% 26
2022
Q3
$28.8M Hold
7,182,850
0.76% 26
2022
Q2
$81.2M Hold
7,182,850
1.74% 15
2022
Q1
$117M Hold
7,182,850
2.44% 11
2021
Q4
$340M Hold
7,182,850
5.26% 5
2021
Q3
$521M Buy
7,182,850
+566,680
+9% +$41M 6.81% 3
2021
Q2
$555M Hold
6,616,170
5.72% 4
2021
Q1
$321M Buy
6,616,170
+5,119,630
+342% +$278M 3.17% 10
2020
Q4
$70.6M Hold
1,496,540
0.56% 28
2020
Q3
$70.4M Buy
+1,496,540
New +$49.3M 0.53% 27

Other funds holding NBP

HHLR Advisors's NBP Position: Q1 2026 in Review

HHLR Advisors held its NovaBridge Biosciences American Depositary Shares (NBP) position steady in Q1 2026 at 5,980,568 shares worth $14.7M. The position accounts for 0.88% of the portfolio, ranked #12.

HHLR Advisors first reported a position in NBP in Q3 2020 and has held it in 23 quarters since. The position peaked at $555M in Q2 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

  • HHLR Advisors held 5,980,568 shares of NovaBridge Biosciences American Depositary Shares worth $14.7M as of Q1 2026.
  • HHLR Advisors left its NovaBridge Biosciences American Depositary Shares share count unchanged in Q1 2026.
  • NovaBridge Biosciences American Depositary Shares made up 0.88% of HHLR Advisors's portfolio in Q1 2026, its #12 holding.
  • HHLR Advisors first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2020 and has held it in 23 quarters since.
  • HHLR Advisors's NovaBridge Biosciences American Depositary Shares position peaked at $555M in Q2 2021.
  • 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on HHLR Advisors's 13F filing for Q1 2026, filed 15 May 2026.